Ashley Woods
4PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 01, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.Ashley C Woods, E Dianne Pulte, Xin Wang
|Oct 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation.Ashley C Woods, Kelly J Norsworthy, Moran Choe
|Nov 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.Ashley Woods, Kelly J Norsworthy, Xin Wang
|Oct 14, 2023
Differentiation Syndrome in Acute Leukemia: APL and Beyond.Ashley C Woods, Kelly J Norsworthy
Pageof 1
Frequent Collaborators
3 joint publications
Kelly J Norsworthy
3 joint publications
Marc R Theoret
3 joint publications
R Angelo de Claro
3 joint publications
Jonathon Vallejo
3 joint publications
Richard Pazdur
2 joint publications
Xiling Jiang
2 joint publications
Hongshan Li
2 joint publications
Olanrewaju O Okusanya
2 joint publications
Jiang Liu
2 joint publications
Rosane Charlab
